These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 6843911)

  • 21. Milk and casein-based diets for the study of brain catecholamines in copper-deficient rats.
    Miller DS; O'Dell BL
    J Nutr; 1987 Nov; 117(11):1890-7. PubMed ID: 2824730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rodent brain and heart catecholamine levels are altered by different models of copper deficiency.
    Pyatskowit JW; Prohaska JR
    Comp Biochem Physiol C Toxicol Pharmacol; 2007 Mar; 145(2):275-81. PubMed ID: 17287146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electroconvulsive shock and neurotransmitter receptors: implications for mechanism of action and adverse effects of electroconvulsive therapy.
    Lerer B
    Biol Psychiatry; 1984 Mar; 19(3):361-83. PubMed ID: 6144329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [H3-dopamine and H3-quinuclidinylbenzilate binding by autonomic ganglia tissue in rats of various age].
    Iarygin VN; Glinkina VV; Kniazeva LA; Lagkueva FK; Pylaev AS
    Biull Eksp Biol Med; 1990 Jun; 109(6):597-8. PubMed ID: 2397305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of surgical ovariectomy on dopamine receptors of the heart and brain].
    Kharchilava OM; Valeeva LA
    Patol Fiziol Eksp Ter; 2008; (4):21-3. PubMed ID: 19202617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent regional changes in brain copper, cuproenzymes and catecholamines following perinatal copper deficiency in mice.
    Prohaska JR; Bailey WR
    J Nutr; 1993 Jul; 123(7):1226-34. PubMed ID: 8391562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoradiographic distributions of neurotransmitter receptors in the human brains of Parkinson's disease and primate models of MPTP-induced parkinsonism.
    Kito S; Miyoshi R; Mizuno K; Nitta K; Matsubayashi H; Yamamura Y; Tahara E
    Adv Neurol; 1987; 45():159-65. PubMed ID: 2881441
    [No Abstract]   [Full Text] [Related]  

  • 28. Interactions of neuroleptic metabolites with dopaminergic, alpha adrenergic and muscarinic cholinergic receptors.
    Bylund DB
    J Pharmacol Exp Ther; 1981 Apr; 217(1):81-6. PubMed ID: 6110776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current status of pharmacological receptors in mammalian central nervous system.
    Banerjee PK; Sen AP; Bhattacharya SK
    Indian J Exp Biol; 1989 Apr; 27(4):310-6. PubMed ID: 2553590
    [No Abstract]   [Full Text] [Related]  

  • 30. The brain cholinergic system in ageing mammals.
    Pepeu G; Casamenti F; Pepeu IM; Scali C
    J Reprod Fertil Suppl; 1993; 46():155-62. PubMed ID: 8315616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zinc or copper deficiency-induced impaired inflammatory response to brain trauma may be caused by the concomitant metallothionein changes.
    Penkowa M; Giralt M; Thomsen PS; Carrasco J; Hidalgo J
    J Neurotrauma; 2001 Apr; 18(4):447-63. PubMed ID: 11336445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The distribution of dopamine D1 and D2 receptors in the brain of rodents and carnivores].
    Avgustinovich DF; Nikulina EM
    Zh Evol Biokhim Fiziol; 1992; 28(1):3-8. PubMed ID: 1387995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scopolamine-induced hypermotility in rats is mediated via a dopaminergic system.
    Fink H; Morgenstern R
    Acta Biol Med Ger; 1980; 39(8-9):903-10. PubMed ID: 7282220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas.
    Gastinger MJ; Singh RS; Barber AJ
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3143-50. PubMed ID: 16799061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of p-chloromercuribenzoate on muscarinic receptor binding in rat brain [proceedings].
    Birdsall NJ; Burgen AS; Hulme EC; Wong EH
    Br J Pharmacol; 1980 Jan; 68(1):142P-143P. PubMed ID: 7357157
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on interactions between striatal dopaminergic and cholinergic mechanisms in the early abstinence after chronic treatment with barbital in the rat.
    Persson SA; Wahlström G
    Subst Alcohol Actions Misuse; 1984; 5(3):149-57. PubMed ID: 6438820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcellular localization of dopamine-sensitive adenylate cyclase and dopamine receptor binding activities.
    Clement-Courmier Y; George R
    Life Sci; 1978 Aug; 23(6):539-43. PubMed ID: 692278
    [No Abstract]   [Full Text] [Related]  

  • 38. Biochemical characterization of the muscarinic cholinergic receptor in human brain: alterations in Huntington's disease.
    Wastek GJ; Yamamura HI
    Mol Pharmacol; 1978 Sep; 14(5):768-80. PubMed ID: 152407
    [No Abstract]   [Full Text] [Related]  

  • 39. Time-dependent changes in rat brain cholinergic receptor expression after experimental brain injury.
    Verbois SL; Scheff SW; Pauly JR
    J Neurotrauma; 2002 Dec; 19(12):1569-85. PubMed ID: 12542858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding assay for muscarinic cholinergic receptors in kaolin induced hydrocephalus.
    Mori K; Fujito K; Kamimura Y
    Nihon Geka Hokan; 1984 Nov; 53(6):695-702. PubMed ID: 6534306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.